Showing all 12 results
Aceclofenac & Paracetamol Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated Tablet, engineered for rapid disintegration and synchronized absorption.
Active Ingredient Strength Primary Clinical Function Aceclofenac USP/BP 100 mg The Anti-Inflammatory: Targets tissue inflammation and reduces joint stiffness. Paracetamol USP/BP 325 mg / 500 mg The Analgesic: Provides rapid relief from acute pain and manages fever. Excipients Proprietary Matrix Rapid-Release System: Engineered to ensure both APIs reach therapeutic levels within 30–60 minutes. Acenocoumarol Tablets
FreeProduct Composition & Strength
We supply this product in multiple strengths to allow for the precise, micro-gram level titration required for safe anticoagulation.
Active Ingredient Strength Primary Clinical Function Acenocoumarol USP/BP/Ph.Eur. 1 mg / 2 mg The Titration Unit: Used for fine-tuning the maintenance dose to keep the INR within the target range (usually 2.0–3.0). Acenocoumarol USP/BP/Ph.Eur. 3 mg / 4 mg The Loading/Anchor Dose: Used for initial therapy or for patients requiring higher systemic anticoagulation. Excipients Proprietary Matrix Bio-Stable System: Engineered to ensure consistent oral absorption and predictable pharmacokinetics. Amiloride & Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product in the globally standardized strength ratio, packed in high-barrier Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Amiloride (as HCl) USP/BP 5 mg The Potassium Guard: Prevents the loss of potassium, protecting against heart arrhythmias and muscle weakness. Hydrochlorothiazide USP/BP 50 mg The Volume Reducer: Excretes excess sodium and water to reduce the load on the heart and vessels. Excipients Proprietary Matrix Steady-State Release System: Engineered to ensure a consistent diuretic effect over a full 24-hour cycle. Amlodipine & Hydrochlorothiazide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, engineered for synchronized 24-hour hemodynamic control.
Active Ingredient Strength Primary Clinical Function Amlodipine (as Besylate) USP/BP 5 mg / 10 mg The Vasodilator: Reduces the resistance of blood vessels to lower systemic pressure. Hydrochlorothiazide USP/BP 12.5 mg / 25 mg The Volume Reducer: Excretes excess sodium and water to reduce circulatory load. Excipients Proprietary Matrix Steady-State System: Engineered to ensure consistent plasma concentrations of both drugs to prevent “dips” in BP control. Atenolol & S-Amlodipine Besylate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, utilizing high-purity S-Amlodipine Besylate to ensure stability.
Active Ingredient Strength Primary Clinical Function Atenolol USP/BP 25 mg / 50 mg The Heart Rate Regulator: Controls the “Pump” by reducing heart rate and myocardial oxygen demand. S-Amlodipine (as Besylate) USP/BP 2.5 mg / 5 mg The Vessel Relaxant: Pure chiral isomer for maximum vasodilation with minimum side effects (edema). Excipients Proprietary Matrix Chiral-Stability System: Engineered to ensure the S-enantiomer remains stable and does not racemize during the shelf-life. Atorvastatin & Aspirin and Clopidogrel Tablets
FreeProduct Composition & Strength
We supply this product typically in a Capsule-in-Capsule or Multi-Particulate Tablet format to ensure the chemical stability of the three distinct APIs.
Active Ingredient Strength Primary Clinical Function Atorvastatin (as Calcium) USP 10 mg / 20 mg The Lipid Stabilizer: Lowers cholesterol and prevents the growth of arterial blockages. Aspirin (Gastro-resistant) BP 75 mg / 150 mg The Primary Blood Thinner: Prevents initial platelet activation via the COX pathway. Clopidogrel (as Bisulphate) USP 75 mg The Secondary Blood Thinner: Provides high-level protection against stent thrombosis and recurrent stroke. Atorvastatin & Asprin Tablets
FreeProduct Composition & Strength
We supply this product as a Bi-Layered or Film-Coated Tablet, often utilizing specialized enteric coating for the Aspirin component to protect the stomach lining.
Active Ingredient Strength Primary Clinical Function Atorvastatin Calcium USP/BP 10 mg / 20 mg The Lipid Regulator: Controls cholesterol synthesis in the liver and stabilizes arterial walls. Aspirin (Gastro-resistant) BP 75 mg / 150 mg The Anti-Platelet Anchor: Provides low-dose blood thinning to prevent clot formation. Excipients Proprietary Matrix Gastro-Protective System: Engineered to ensure Aspirin dissolves only in the small intestine, minimizing gastric irritation. Benzthiazide & Triamterene Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Disintegration Tablet, packed in high-barrier Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Benzthiazide USP/BP 25 mg The Thiazide Payload: The primary driver for sodium and water excretion to lower blood pressure. Triamterene USP/BP 50 mg The Potassium Guardian: Physically prevents the loss of Potassium (K+) during the diuretic process. Excipients Proprietary Matrix Bio-Balance System: Engineered to ensure synchronized dissolution of both active APIs for maximum clinical synergy. Ibuprofen with Paracetamol Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) designed for maximum therapeutic synergy and patient safety.
Active Ingredient Standard Strengths (per Tablet) Primary Clinical Function Ibuprofen IP/BP/USP 200 mg / 400 mg The Anti-Inflammatory: Reduces physical swelling. Paracetamol IP/BP/USP 325 mg / 500 mg The Analgesic: Raises the chemical pain threshold. Excipients Pharma Grade The Matrix: Ensures stability and rapid release. Lisinopril Tablet
FreeProduct Composition & Available Portfolio Range
We manufacture Lisinopril in exact, compendial strengths calibrated to support initial introductory titration up to high-potency cardioprotective maintenance blocks.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Lisinopril Anhydrous / Dihydrate USP / BP / IP 5 mg Oral Solid Uncoated Tablet Initial Titration: For low-dose introductory management, pediatric hypertension, or initial combination therapy initiation. Lisinopril Anhydrous / Dihydrate USP / BP / IP 10 mg Oral Solid Uncoated Tablet Core Commercial Volume: Standard international baseline daily dose for mild-to-moderate chronic essential hypertension. Lisinopril Anhydrous / Dihydrate USP / BP / IP 20 mg Oral High-Potency Solid Tablet Advanced Cardioprotection: High-strength configuration calibrated for severe heart failure management and post-infarction survival optimization.




